Perampanel in real‐world clinical care of patients with epilepsy: Interim analysis of a phase IV study-Reference-Cited by-同舟云学术

Perampanel in real‐world clinical care of patients with epilepsy: Interim analysis of a phase IV study

Published:2020-12-19 Issue:1 Volume:6 Page:79-89
ISSN:2470-9239
Container-title:Epilepsia Open
language:en
Short-container-title:Epilepsia Open

Author:

Wheless James¹^ORCID,Wechsler Robert T.²^ORCID,Lancman Marcelo³,Aboumatar Sami⁴,Patten Anna⁵,Malhotra Manoj⁶

Affiliation:

1. University of Tennessee Health Science Center Le Bonheur Children’s Hospital Memphis TN USA

2. Idaho Comprehensive Epilepsy Center Boise ID USA

3. Northeast Regional Epilepsy Group Hackensack NJ USA

4. Austin Epilepsy Care Center Austin TX USA

5. Eisai Ltd. Hatfield Hertfordshire UK

6. Eisai Inc. Woodcliff Lake NJ USA

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/epi4.12445

Reference20 articles.

1. European Medicines Agency (EMA).Fycompa®Annex I: Summary of Product Characteristics July 2020.. Available fromhttps://www.ema.europa.eu/en/documents/product‐information/fycompa‐epar‐product‐information_en.pdf. Accessed October 5 2020.

2. Food and Drug Administration (FDA).Fycompa®Prescribing Information September 2020. Available from:https://www.fycompa.com/‐/media/Files/Fycompa/Fycompa_Prescribing_Information.pdf. Accessed October 5 2020.

3. Adjunctive perampanel for refractory partial-onset seizures: Randomized phase III study 304

4. Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: Results of randomized global phase III study 305

5. Randomized phase III study 306: Adjunctive perampanel for refractory partial-onset seizures

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of perampanel by etiology in Japanese patients with epilepsy—subpopulation analysis of a prospective post‐marketing observational study;Epilepsia Open;2024-07-04

2. Time to prerandomization seizure count design sufficiently assessed the safety and tolerability of perampanel for the treatment of primary generalized tonic–clonic seizures;Epilepsia;2024-06-12

3. Phase IV PROVE study: Perampanel in real-world clinical care of pediatric patients with epilepsy;European Journal of Paediatric Neurology;2024-05

4. Effectiveness and tolerability of adjunctive perampanel in pediatric patients (aged 4–12 years) with refractory epilepsy: An observational study;Medicine;2022-11-11

5. Efficacy and adverse reactions of perampanel in the treatment of epilepsy in children;Frontiers in Neurology;2022-07-27